Results 191 to 200 of about 387,869 (336)

Antibody Production in Response to Hepatitis B Surface Antigen in a Combination Hepatitis A/Hepatitis B Vaccine [PDF]

, 2000
Betsy Abraham, Dennis Parenti
openalex   +1 more source

Revaccination Response and Lack of Hepatitis B Reactivation After HCT for Sickle Cell Disease

Transplant Infectious Disease, EarlyView.
At baseline, 55% of sickle cell patients showed HBV immunity, and 93% received post HCT revaccination, with 89% completing the series. Between Years 1–2, 67.5% of vaccinated patients had rising anti HBs titers. No HBV reactivation occurred, though nonresponders under heavy immunosuppression need further study.
Henna Butt, Neal Jeffries, Triscia Martin, Valeria De Giorgi, Alison Zamora, John F. Tisdale, Matthew M. Hsieh   +6 more
wiley   +1 more source

Birth-dose hepatitis B vaccine and bronchopulmonary dysplasia risks in preterm infants. [PDF]

Bull World Health Organ
Daley MF, Glanz JM.
europepmc   +1 more source

COVID‐19 pandemic impact on blood donations and discards from screening tests for transfusion‐transmitted infections in a Brazil Brazilian metropolitan area

Transfusion Medicine, EarlyView.
Abstract Background The COVID‐19 pandemic posed a worldwide challenge for blood services. We aimed to evaluate the impact of the COVID‐19 pandemic on blood donations and blood discards resulting from screening tests for transfused‐transmitted infections (TTIs) in a Brazilian metropolitan.
Laiane da Silva Santos, Sérgio Eduardo Soares Fernandes, Flávio Ferreira Pontes Amorim, Anna Luiza Oliveira Sant'Anna, Felipe Ferreira Pontes Amorim, Fábio Ferreira Amorim   +5 more
wiley   +1 more source

Hepatitis B vaccine

The Pediatric Infectious Disease Journal, 1982
openaire   +5 more sources

Effect of the interval between birth and second dose of hepatitis B vaccine on perinatal transmission of hepatitis B virus. [PDF]

Hum Vaccin Immunother, 2023
Yang TU, Vargas-Zambrano JC, Park HA, Jung CW, Kim D, Jee Y.   +5 more
europepmc   +1 more source

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR IMPROVES IMMUNOGENECITY OF HEPATITIS B VACCINE IN HEMODIALYSIS PATIENTS [PDF]

, 2000
PP VARMA, AK SETH, Rohan Malik, Chinmaya Mahapatra, PVS Rana   +4 more
openalex   +1 more source

How do I interpret transfusion transmissible infectious disease testing in a low‐risk donor population?

Transfusion, EarlyView.
Abstract Background Blood donors represent a unique population. Pre‐donation screening questions, donor self‐deferral, and temporary deferral and re‐testing of repeat reactive donors result in lower prevalence of infectious disease compared to the general population.
Carmen L. Charlton, Mark Bigham, Sheila F. O'Brien, Steven J. Drews   +3 more
wiley   +1 more source

Primary care physicians' perspectives on adults with diabetes and the recommended hepatitis B vaccine: A qualitative study. [PDF]

PLoS One
Müller DL, Stuckey H, Flores ES, Wang L, Godfrey T, Calo WA, Yingst J.   +6 more
europepmc   +1 more source

Reduced protective efficacy of hepatitis B vaccine among fully vaccinated children in Ethiopia. [PDF]

PLoS One, 2023
Adugna A, Demeke G, Toru M, Tsehay D, Esmael A, Mihret A, Mulu A.   +6 more
europepmc   +1 more source